FindTrial
Sign In

The study of serum microRNA marker for anti-virus treatment and prognosis in patients with chronic hepatitis B

The study of serum microRNA marker for anti-virus treatment and prognosis in patients with chronic hepatitis B

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-17012601
Enrollment
Unknown
Registered
2017-09-07
Start date
2017-10-01
Completion date
Unknown
Last updated
2017-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic hepatitis B

Interventions

Control group:No intervention
HBV patient group:No intervention

Sponsors

Shanghai 6th Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: health people and chronic hepatitis B patients

Exclusion criteria

Exclusion criteria: HBV/HCV or HBV/HIV co-infection

Design outcomes

Primary

MeasureTime frame
mir-122;mir-155;—

Countries

China

Contacts

Public ContactYingzhi Wang

Laboatory of Immunology, Shanghai 6th Hospital

winniewin@163.com+86 021-24058732

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026